Analyst Ratings February 10, 2026

DA Davidson Lifts Timken Price Target to $108, Keeps Neutral Rating Amid Mixed Signals

Analyst hike follows solid Q4 2025 results; firm stays cautious pending product updates and clearer 2026 trajectory

By Avery Klein TKR
DA Davidson Lifts Timken Price Target to $108, Keeps Neutral Rating Amid Mixed Signals
TKR

DA Davidson increased its 12-month price target on Timken Co. to $108 from $86 while retaining a Neutral rating after the company's fourth-quarter 2025 report. The upgrade follows better-than-expected quarterly results and strong recent share performance, but the research firm signaled caution until management provides more detail on product initiatives and the company’s outlook for 2026.

Key Points

  • DA Davidson raised Timken’s price target to $108 from $86 but maintained a Neutral rating.
  • Timken reported 5.6% organic growth in Q4 2025 and a "flattish" outlook for Q1 2026; trailing twelve-month diluted EPS was $4.11 versus analyst expectations of $5.78 for fiscal 2026.
  • Timken beat Q4 2025 consensus with EPS of $1.14 and revenue of $1.11 billion; KeyBanc upgraded the stock to Overweight with a $130 target, citing industrial cycle expectations and potential value creation under CEO Lucian Boldea.

Analyst move

DA Davidson raised its price objective for Timken Co. (TKR) to $108.00 from $86.00, yet left its coverage stance at Neutral. The firm’s revised target comes as the shares trade roughly in line with the new level, with the stock quoted at $108.87 and sitting close to a 52-week high of $109.43. The shares have appreciated 13.3% over the past week and about 47.75% over the last six months, per available market data.

Drivers behind the change

The price-target increase follows Timken’s fourth-quarter 2025 earnings release. Management reported 5.6% organic growth for the period, a figure DA Davidson described as being driven in part by "easy comps." Timken also flagged a "flattish" outlook for the first quarter of 2026, tempering near-term visibility for growth.

Despite leaving its rating unchanged, DA Davidson wrote that there are "high" chances Timken could finish 2026 "on a high note." The firm said it expects additional disclosure on new-product development aimed at faster-growth end markets, calling out humanoid robots and robotics more broadly as target areas. Timken reported diluted earnings per share of $4.11 for the trailing twelve months, while analyst consensus for fiscal 2026 stands at $5.78 per share.

Upcoming catalysts and positioning

Timken has an Investor Day scheduled for May 2026. DA Davidson anticipates the company will provide further information about its product-development pipeline and progress on so-called "80-20" initiatives at that event. Even with the material bump to the price target, the research firm said it is remaining "on the sidelines, waiting for the right entry point."

Quarterly performance and other analyst views

Timken’s fourth-quarter 2025 results outpaced internal forecasts: GAAP diluted EPS for the quarter came in at $1.14 versus a consensus expectation of $1.09, and revenue reached $1.11 billion compared with an anticipated $1.07 billion. These figures underline a stronger-than-expected quarter for the industrial bearings and power transmission products maker.

Separately, KeyBanc Capital Markets upgraded Timken’s rating from Sector Weight to Overweight and set a $130.00 price target. KeyBanc attributed the change to expectations for an industrial cycle inflection and potential value creation under the company’s new CEO, Lucian Boldea. Collectively, the differing analyst views and the upcoming Investor Day establish a sequence of data points that market participants will likely use to reassess the company’s medium-term outlook.

Conclusion

The DA Davidson price-target increase to $108 reflects a reassessment of Timken’s valuation following solid quarterly results and notable share performance. At the same time, the firm’s Neutral rating and its statement that it is waiting for a better entry point highlight lingering caution until management provides clearer signals on product strategy execution and 2026 trajectory.

Risks

  • Near-term demand uncertainty - Timken signaled a "flattish" start to 2026, which could affect industrial end markets and supply-chain reliant sectors.
  • Execution and product-development clarity - The company’s progress on new-product initiatives targeting robotics, including humanoid robots, will be a key determinant; limited disclosure until Investor Day introduces execution risk.
  • Valuation sensitivity - With shares trading near a 52-week high and mixed analyst stances, investor returns may hinge on upcoming catalysts and confirmation of sustained margin or revenue expansion.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026